Today’s pre-market rise of Apple (AAPL) stock follows its CEO’s announcement about designing and producing face shields for medical workers. The company is already in the process of donating over 20 million masks to healthcare professionals.
Microsoft co-founder and philanthropist Bill Gates, who warned five years ago that the world’s greatest threat is a pandemic, believes that the current coronavirus crisis is “a nightmare scenario” but it could be worse.
Luckin Coffee’s investors “should no longer rely upon” its previous financial statements over the last three quarters of 2019, as the figures have been faked by its COO Jian Liu.
According to Moderna Chairman Noubar Afeyan, the second phase of human trials of the COVID-19 vaccine might begin this spring. If the testing is successful, the 3rd phase will immediately begin. MRNA stock went up.
Top five Dow Jones stocks in Q1 include Microsoft (MSFT), Walmart (WMT), followed by Intel (INTC), Johnson & Johnson (JNJ), and Procter & Gamble (PG).
According to Detroit Mayor Mike Duggan, Abbott Laboratories COVID-19 tests are already available for first responders who are self-isolating but have yet to test positive for the virus. ABT stock was down yesterday.
As COVID-19 continues to spread, technology stock prices have fallen in tandem with the general market. However, such tech stocks as MSFT and AMZN could also become the market leaders.
Ford (F) stock price is unstable while the company is preparing to produce 50,000 GE ventilators in collaboration with Generic Electric to help coronavirus patients.
Abbott Laboratories (ABT) stock rises further following the company’s announcement about its system for identifying coronavirus. Today, during the pre-market hours, Abbott Laboratories shares were 8.77% up. Now they are 6.83% up.
As Amazon predicts, its Q1 2020 net sales will rise by a range of 16% and 22% to hit $73 billion. In addition, the company has boasted more members already joined its subscription program. AMZN stock is rising in the pre-market.
Editors’ Choice category presents the latest articles, hand-picked by the Coinspeaker’s editor.
